Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2513-2524
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2513
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2513
n = 106 | ||
Age (yr) | 57.5 ± 7.8 | |
Gender | ||
Male | 81 (76.42) | |
Female | 25 (23.58) | |
Tumor length (cm) | 5.02 ± 1.85 | |
Pathological T staging | ||
T1 | 25 (23.58) | |
T2 | 28 (26.42) | |
T3 | 34 (32.08) | |
T4 | 19 (17.92) | |
Pathological N staging | ||
N0 | 37 (34.91) | |
N1 | 27 (25.47) | |
N2 | 20 (18.87) | |
N3 | 22 (20.75) | |
Tissue typing | ||
Adenocarcinoma | 83 (78.30) | |
Signet-ring cell carcinoma | 17 (16.04) | |
Neuroendocrine carcinoma | 6 (5.66) | |
Degree of differentiation | ||
High differentiation | 32 (30.19) | |
Moderate differentiation | 55 (51.89) | |
Low differentiation | 19 (17.92) |
- Citation: Liu H, Zhao KY. Application of CD34 expression combined with three-phase dynamic contrast-enhanced computed tomography scanning in preoperative staging of gastric cancer. World J Gastrointest Surg 2023; 15(11): 2513-2524
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2513.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2513